Concepts (238)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cognitive Dysfunction | 18 | 2024 | 235 | 3.890 |
Why?
|
| Aging | 17 | 2023 | 352 | 3.260 |
Why?
|
| Cognition | 25 | 2024 | 337 | 2.900 |
Why?
|
| Aged | 61 | 2024 | 1860 | 2.410 |
Why?
|
| Alzheimer Disease | 22 | 2024 | 409 | 2.270 |
Why?
|
| Cognition Disorders | 15 | 2022 | 237 | 2.210 |
Why?
|
| Aged, 80 and over | 41 | 2024 | 1034 | 1.750 |
Why?
|
| Humans | 68 | 2024 | 5837 | 1.720 |
Why?
|
| Female | 55 | 2024 | 3346 | 1.660 |
Why?
|
| Male | 54 | 2024 | 3399 | 1.640 |
Why?
|
| Stress, Psychological | 4 | 2023 | 58 | 1.590 |
Why?
|
| Dementia | 10 | 2024 | 127 | 1.200 |
Why?
|
| Motor Activity | 5 | 2016 | 83 | 1.100 |
Why?
|
| Memory Disorders | 4 | 2023 | 48 | 1.030 |
Why?
|
| Tissue Donors | 2 | 2020 | 28 | 1.010 |
Why?
|
| Depression | 4 | 2020 | 113 | 0.970 |
Why?
|
| Middle Aged | 19 | 2024 | 1775 | 0.940 |
Why?
|
| HIV Infections | 2 | 2017 | 135 | 0.900 |
Why?
|
| Family | 3 | 2021 | 26 | 0.840 |
Why?
|
| Neuropsychological Tests | 18 | 2024 | 309 | 0.830 |
Why?
|
| Arteriolosclerosis | 1 | 2023 | 14 | 0.800 |
Why?
|
| Genetic Predisposition to Disease | 9 | 2018 | 123 | 0.770 |
Why?
|
| Flavonols | 1 | 2022 | 5 | 0.760 |
Why?
|
| Independent Living | 2 | 2021 | 62 | 0.710 |
Why?
|
| Risk Factors | 14 | 2024 | 499 | 0.700 |
Why?
|
| Loneliness | 3 | 2017 | 22 | 0.680 |
Why?
|
| Cognitive Aging | 3 | 2018 | 27 | 0.660 |
Why?
|
| Longitudinal Studies | 19 | 2024 | 363 | 0.620 |
Why?
|
| Patient Selection | 3 | 2020 | 48 | 0.600 |
Why?
|
| Cohort Studies | 13 | 2024 | 406 | 0.590 |
Why?
|
| United States | 14 | 2024 | 502 | 0.580 |
Why?
|
| Geriatric Assessment | 7 | 2016 | 59 | 0.530 |
Why?
|
| Chicago | 13 | 2024 | 239 | 0.530 |
Why?
|
| Cross-Sectional Studies | 6 | 2024 | 203 | 0.520 |
Why?
|
| Brain | 6 | 2024 | 331 | 0.470 |
Why?
|
| Factor Analysis, Statistical | 1 | 2015 | 15 | 0.470 |
Why?
|
| Mobility Limitation | 1 | 2015 | 16 | 0.460 |
Why?
|
| Motor Disorders | 1 | 2015 | 4 | 0.460 |
Why?
|
| Follow-Up Studies | 11 | 2017 | 333 | 0.430 |
Why?
|
| Life Change Events | 1 | 2012 | 12 | 0.380 |
Why?
|
| Membrane Transport Proteins | 3 | 2017 | 29 | 0.380 |
Why?
|
| Apolipoproteins E | 5 | 2018 | 55 | 0.370 |
Why?
|
| Disability Evaluation | 4 | 2016 | 60 | 0.370 |
Why?
|
| Apolipoprotein E4 | 4 | 2018 | 92 | 0.360 |
Why?
|
| Educational Status | 4 | 2021 | 60 | 0.310 |
Why?
|
| Cardiovascular Diseases | 2 | 2024 | 77 | 0.310 |
Why?
|
| Memory | 5 | 2016 | 61 | 0.310 |
Why?
|
| Genotype | 7 | 2018 | 114 | 0.300 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2017 | 72 | 0.300 |
Why?
|
| Wearable Electronic Devices | 2 | 2019 | 13 | 0.290 |
Why?
|
| Prospective Studies | 5 | 2022 | 411 | 0.280 |
Why?
|
| Self Report | 2 | 2020 | 53 | 0.270 |
Why?
|
| Clinical Trials as Topic | 2 | 2020 | 51 | 0.250 |
Why?
|
| Homozygote | 2 | 2017 | 6 | 0.240 |
Why?
|
| Reaction Time | 2 | 2016 | 39 | 0.230 |
Why?
|
| Dietary Approaches To Stop Hypertension | 1 | 2024 | 10 | 0.210 |
Why?
|
| Diet, Mediterranean | 1 | 2024 | 19 | 0.210 |
Why?
|
| Prejudice | 1 | 2004 | 9 | 0.210 |
Why?
|
| Disease Progression | 5 | 2017 | 157 | 0.210 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2024 | 25 | 0.200 |
Why?
|
| Biomarkers | 1 | 2024 | 141 | 0.190 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 2023 | 28 | 0.190 |
Why?
|
| Quercetin | 1 | 2022 | 5 | 0.190 |
Why?
|
| Kaempferols | 1 | 2022 | 5 | 0.190 |
Why?
|
| Models, Psychological | 2 | 2015 | 11 | 0.190 |
Why?
|
| Perception | 2 | 2021 | 30 | 0.190 |
Why?
|
| Eating | 1 | 2022 | 16 | 0.190 |
Why?
|
| Memory, Short-Term | 1 | 2022 | 37 | 0.190 |
Why?
|
| Accelerometry | 2 | 2019 | 14 | 0.180 |
Why?
|
| Blood Glucose | 1 | 2022 | 30 | 0.180 |
Why?
|
| Desegregation | 1 | 2021 | 1 | 0.180 |
Why?
|
| Social Discrimination | 1 | 2021 | 5 | 0.170 |
Why?
|
| Music | 1 | 2021 | 8 | 0.170 |
Why?
|
| Death | 1 | 2021 | 11 | 0.170 |
Why?
|
| Attitude to Death | 1 | 2020 | 4 | 0.170 |
Why?
|
| Literacy | 1 | 2021 | 9 | 0.170 |
Why?
|
| Tissue and Organ Procurement | 1 | 2020 | 12 | 0.160 |
Why?
|
| Autopsy | 1 | 2020 | 67 | 0.160 |
Why?
|
| Reading | 2 | 2021 | 9 | 0.160 |
Why?
|
| Healthy Volunteers | 1 | 2020 | 4 | 0.160 |
Why?
|
| Health Behavior | 1 | 2020 | 42 | 0.160 |
Why?
|
| Psychometrics | 3 | 2012 | 52 | 0.160 |
Why?
|
| Surveys and Questionnaires | 3 | 2017 | 284 | 0.150 |
Why?
|
| Activities of Daily Living | 2 | 2013 | 75 | 0.150 |
Why?
|
| Parkinsonian Disorders | 1 | 2019 | 43 | 0.140 |
Why?
|
| Cerebrovascular Disorders | 1 | 2018 | 19 | 0.140 |
Why?
|
| Postural Balance | 1 | 2018 | 26 | 0.140 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2018 | 28 | 0.140 |
Why?
|
| Linear Models | 5 | 2017 | 64 | 0.140 |
Why?
|
| Residence Characteristics | 2 | 2015 | 43 | 0.140 |
Why?
|
| Neuropathology | 1 | 2018 | 17 | 0.140 |
Why?
|
| Plant Leaves | 1 | 2017 | 1 | 0.140 |
Why?
|
| Phytochemicals | 1 | 2017 | 1 | 0.140 |
Why?
|
| Vegetables | 1 | 2017 | 8 | 0.140 |
Why?
|
| Genome-Wide Association Study | 2 | 2015 | 66 | 0.130 |
Why?
|
| Phospholipase C gamma | 1 | 2017 | 2 | 0.130 |
Why?
|
| Receptors, Immunologic | 1 | 2017 | 3 | 0.130 |
Why?
|
| Membrane Glycoproteins | 1 | 2017 | 18 | 0.130 |
Why?
|
| Adult | 4 | 2018 | 1670 | 0.130 |
Why?
|
| Haplotypes | 1 | 2017 | 19 | 0.130 |
Why?
|
| Immunity, Innate | 1 | 2017 | 13 | 0.130 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2017 | 21 | 0.130 |
Why?
|
| Polymorphism, Genetic | 1 | 2017 | 26 | 0.130 |
Why?
|
| Microglia | 1 | 2017 | 25 | 0.130 |
Why?
|
| Apolipoprotein E3 | 1 | 2017 | 5 | 0.130 |
Why?
|
| Memory, Episodic | 1 | 2017 | 26 | 0.130 |
Why?
|
| Incidence | 4 | 2018 | 165 | 0.130 |
Why?
|
| Psychomotor Performance | 2 | 2015 | 48 | 0.130 |
Why?
|
| Genetic Variation | 1 | 2017 | 23 | 0.130 |
Why?
|
| Parkinson Disease | 1 | 2018 | 134 | 0.120 |
Why?
|
| Agnosia | 1 | 2016 | 3 | 0.120 |
Why?
|
| Diabetes Complications | 1 | 2016 | 15 | 0.120 |
Why?
|
| Task Performance and Analysis | 1 | 2016 | 18 | 0.120 |
Why?
|
| Statistics, Nonparametric | 2 | 2015 | 28 | 0.120 |
Why?
|
| Seafood | 1 | 2016 | 6 | 0.120 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2016 | 8 | 0.120 |
Why?
|
| Feeding Behavior | 1 | 2016 | 25 | 0.120 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2016 | 45 | 0.120 |
Why?
|
| Olfaction Disorders | 1 | 2016 | 8 | 0.120 |
Why?
|
| Anxiety Disorders | 1 | 2016 | 35 | 0.120 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 71 | 0.110 |
Why?
|
| Illinois | 1 | 2015 | 52 | 0.110 |
Why?
|
| Time Factors | 4 | 2017 | 374 | 0.110 |
Why?
|
| Sex Characteristics | 1 | 2015 | 36 | 0.110 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2015 | 3 | 0.110 |
Why?
|
| Mental Status Schedule | 4 | 2018 | 32 | 0.110 |
Why?
|
| Colonoscopy | 1 | 2015 | 12 | 0.110 |
Why?
|
| Colorectal Neoplasms | 1 | 2015 | 16 | 0.110 |
Why?
|
| Patient Compliance | 1 | 2015 | 35 | 0.110 |
Why?
|
| Mass Screening | 1 | 2015 | 31 | 0.110 |
Why?
|
| DNA-Binding Proteins | 1 | 2015 | 94 | 0.110 |
Why?
|
| Early Detection of Cancer | 1 | 2015 | 25 | 0.110 |
Why?
|
| Genetic Loci | 1 | 2014 | 16 | 0.110 |
Why?
|
| Interviews as Topic | 3 | 2021 | 44 | 0.100 |
Why?
|
| Urban Population | 1 | 2013 | 34 | 0.100 |
Why?
|
| Cerebral Infarction | 2 | 2011 | 29 | 0.100 |
Why?
|
| Child | 2 | 2012 | 339 | 0.100 |
Why?
|
| Health Status Disparities | 1 | 2013 | 17 | 0.100 |
Why?
|
| Hospitalization | 1 | 2013 | 86 | 0.100 |
Why?
|
| Odds Ratio | 3 | 2017 | 60 | 0.090 |
Why?
|
| Epidemiologic Studies | 1 | 2012 | 9 | 0.090 |
Why?
|
| Anomie | 1 | 2012 | 2 | 0.090 |
Why?
|
| Research Design | 1 | 2012 | 42 | 0.090 |
Why?
|
| Social Environment | 1 | 2012 | 9 | 0.090 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 163 | 0.090 |
Why?
|
| Case-Control Studies | 3 | 2017 | 136 | 0.090 |
Why?
|
| Life Style | 1 | 2011 | 48 | 0.090 |
Why?
|
| Caregivers | 1 | 2011 | 27 | 0.090 |
Why?
|
| Brazil | 2 | 2021 | 10 | 0.080 |
Why?
|
| Young Adult | 1 | 2012 | 421 | 0.080 |
Why?
|
| Adolescent | 1 | 2012 | 488 | 0.080 |
Why?
|
| Interpersonal Relations | 2 | 2009 | 26 | 0.080 |
Why?
|
| Medicare Part D | 1 | 2009 | 1 | 0.080 |
Why?
|
| Social Behavior | 1 | 2009 | 13 | 0.070 |
Why?
|
| Heterozygote | 2 | 2018 | 59 | 0.060 |
Why?
|
| Genotyping Techniques | 2 | 2017 | 6 | 0.060 |
Why?
|
| Genetic Association Studies | 2 | 2017 | 32 | 0.060 |
Why?
|
| Personality Disorders | 1 | 2006 | 3 | 0.060 |
Why?
|
| Child Abuse | 1 | 2006 | 5 | 0.060 |
Why?
|
| Awareness | 2 | 2016 | 13 | 0.060 |
Why?
|
| Age Factors | 3 | 2015 | 181 | 0.060 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2006 | 54 | 0.060 |
Why?
|
| Life | 1 | 2005 | 2 | 0.060 |
Why?
|
| Retrospective Studies | 2 | 2021 | 584 | 0.060 |
Why?
|
| Logistic Models | 2 | 2016 | 109 | 0.060 |
Why?
|
| Chi-Square Distribution | 2 | 2015 | 32 | 0.060 |
Why?
|
| Exercise | 2 | 2017 | 96 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2024 | 112 | 0.050 |
Why?
|
| Age of Onset | 2 | 2014 | 27 | 0.050 |
Why?
|
| Amyloid beta-Peptides | 1 | 2024 | 41 | 0.050 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2024 | 13 | 0.050 |
Why?
|
| Healthy Lifestyle | 1 | 2024 | 21 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2024 | 25 | 0.050 |
Why?
|
| Cerebral Hemorrhage | 1 | 2023 | 26 | 0.050 |
Why?
|
| Data Interpretation, Statistical | 1 | 2022 | 25 | 0.050 |
Why?
|
| Alleles | 2 | 2018 | 89 | 0.050 |
Why?
|
| Executive Function | 1 | 2022 | 31 | 0.050 |
Why?
|
| Decision Making | 1 | 2022 | 49 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2023 | 207 | 0.050 |
Why?
|
| Sex Factors | 2 | 2015 | 129 | 0.040 |
Why?
|
| California | 1 | 2021 | 16 | 0.040 |
Why?
|
| Schools | 1 | 2021 | 11 | 0.040 |
Why?
|
| Mathematics | 1 | 2021 | 25 | 0.040 |
Why?
|
| Writing | 1 | 2021 | 9 | 0.040 |
Why?
|
| Mental Status and Dementia Tests | 1 | 2021 | 16 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2020 | 54 | 0.040 |
Why?
|
| Fitness Trackers | 1 | 2019 | 5 | 0.040 |
Why?
|
| Prognosis | 1 | 2019 | 138 | 0.040 |
Why?
|
| Diagnostic Techniques, Neurological | 1 | 2018 | 3 | 0.040 |
Why?
|
| Time and Motion Studies | 1 | 2018 | 8 | 0.040 |
Why?
|
| Community Health Planning | 1 | 2018 | 5 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 2017 | 22 | 0.030 |
Why?
|
| Protein Interaction Maps | 1 | 2017 | 2 | 0.030 |
Why?
|
| Exome | 1 | 2017 | 4 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2017 | 11 | 0.030 |
Why?
|
| Linkage Disequilibrium | 1 | 2017 | 11 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2017 | 21 | 0.030 |
Why?
|
| Genetic Linkage | 1 | 2017 | 7 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2017 | 46 | 0.030 |
Why?
|
| Diagnosis | 1 | 2017 | 5 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 34 | 0.030 |
Why?
|
| Smoking | 1 | 2017 | 47 | 0.030 |
Why?
|
| Monitoring, Ambulatory | 1 | 2016 | 6 | 0.030 |
Why?
|
| Hypoglycemic Agents | 1 | 2016 | 16 | 0.030 |
Why?
|
| Neuroprotection | 1 | 2016 | 2 | 0.030 |
Why?
|
| Neuroticism | 1 | 2016 | 6 | 0.030 |
Why?
|
| Gene-Environment Interaction | 1 | 2016 | 9 | 0.030 |
Why?
|
| Demography | 1 | 2016 | 14 | 0.030 |
Why?
|
| Diet | 1 | 2016 | 54 | 0.030 |
Why?
|
| Mental Health | 1 | 2016 | 16 | 0.030 |
Why?
|
| Genes, Recessive | 1 | 2015 | 1 | 0.030 |
Why?
|
| Indiana | 1 | 2015 | 3 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2015 | 64 | 0.030 |
Why?
|
| Brief Psychiatric Rating Scale | 1 | 2015 | 4 | 0.030 |
Why?
|
| Sialic Acid Binding Ig-like Lectin 3 | 1 | 2015 | 3 | 0.030 |
Why?
|
| Chromosome Aberrations | 1 | 2015 | 7 | 0.030 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2015 | 6 | 0.030 |
Why?
|
| Population Surveillance | 1 | 2015 | 20 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2015 | 57 | 0.030 |
Why?
|
| Protective Factors | 1 | 2015 | 8 | 0.030 |
Why?
|
| Sweden | 1 | 2015 | 5 | 0.030 |
Why?
|
| Pedigree | 1 | 2015 | 13 | 0.030 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2015 | 22 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2013 | 67 | 0.020 |
Why?
|
| Multilevel Analysis | 1 | 2012 | 4 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2012 | 13 | 0.020 |
Why?
|
| Microcirculation | 1 | 2011 | 13 | 0.020 |
Why?
|
| Insurance, Pharmaceutical Services | 1 | 2009 | 1 | 0.020 |
Why?
|
| Social Support | 1 | 2009 | 39 | 0.020 |
Why?
|
| Personality Inventory | 1 | 2007 | 12 | 0.020 |
Why?
|
| Social Isolation | 1 | 2007 | 9 | 0.020 |
Why?
|
| Comorbidity | 1 | 2007 | 98 | 0.020 |
Why?
|
| Psychology | 1 | 2006 | 5 | 0.020 |
Why?
|
| Parenting | 1 | 2006 | 7 | 0.020 |
Why?
|
| Social Adjustment | 1 | 2006 | 5 | 0.020 |
Why?
|
| Parent-Child Relations | 1 | 2006 | 4 | 0.020 |
Why?
|
| Parents | 1 | 2006 | 19 | 0.010 |
Why?
|
| Risk | 1 | 2002 | 60 | 0.010 |
Why?
|